Pulse Biosciences Inc.

NASDAQ: PLSE · Real-Time Price · USD
17.37
0.06 (0.35%)
At close: Aug 15, 2025, 10:18 AM

Pulse Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
118.04M 44.37M 61.14M 28.61M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 1.89M -2.73M -3.25M
Other Long-Term Assets
677K -1.52M 365K 365K
Receivables
n/a n/a n/a 61K
Inventory
n/a n/a n/a 5.82M
Other Current Assets
1.41M 963K 1.01M n/a
Total Current Assets
119.45M 45.33M 62.15M 36.63M
Property-Plant & Equipment
8.32M 8.78M 10.02M 11.25M
Goodwill & Intangibles
4.01M 4.68M 5.34M 6.01M
Total Long-Term Assets
13.01M 13.83M 15.73M 17.62M
Total Assets
132.46M 59.15M 77.88M 54.25M
Account Payables
1.67M 1.84M 1.57M 2.9M
Deferred Revenue
n/a n/a n/a 16K
Short-Term Debt
n/a n/a 917K 436K
Other Current Liabilities
1.2M 3.2M 50K 1.46M
Total Current Liabilities
10.05M 6.71M 5.98M 8.52M
Long-Term Debt
n/a n/a 65M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
7.54M 8.09M 74.14M 10.04M
Total Liabilities
17.6M 14.79M 80.13M 18.56M
Total Debt
8.9M 9.14M 75.96M 11.25M
Common Stock
66K 55K 37K 29K
Retained Earnings
-390.5M -336.92M -294.7M -236.2M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
114.86M 44.36M -2.25M 35.69M
Total Investments
n/a 1.89M -2.73M -3.25M